Pricing Log in Create free account

Immunic, Inc. (IMUX) vs LENZ Therapeutics, Inc. (LENZ)

Immunic, Inc. and LENZ Therapeutics, Inc. are both Biotechnology companies. Immunic, Inc. and LENZ Therapeutics, Inc. are of similar size ($99.9M and $94.6M). Immunic, Inc. has the higher net margin (0.00% vs −1,135.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Immunic, Inc. leads on 7 and LENZ Therapeutics, Inc. on 5.

Valuation

Metric IMUX LENZ Biotechnology median
P/E n/m n/m 10.26
P/S n/m 7.73 9.18
P/B 2.46 0.50 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.67 0.65
EV/Sales n/m (8.06) 8.98
Earnings yield (59.35%) (147.55%) (34.89%)
Free cash flow yield (28.06%) (133.70%) (24.52%)

Profitability

Metric IMUX LENZ Biotechnology median
Gross margin 0.00% 85.35% 65.16%
Operating margin 0.00% (1,211.17%) 0.00%
Net margin 0.00% (1,134.97%) 0.00%
Free cash flow margin 0.00% (1,033.28%) 0.00%
Return on equity (138.17%) (72.69%) (50.12%)
Return on assets (101.15%) (66.72%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMUX LENZ Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 38.00% (21.79%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMUX LENZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.05 11.66 4.89
Net debt to EBITDA 0.15 3.22 1.01

Dividend

Metric IMUX LENZ Biotechnology median
Dividend yield — 0.00% 0.41%
Payout ratio — — —

Size

Metric IMUX LENZ Biotechnology median
Market cap 99.88m 94.58m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack